Title: Role of HER2/HER3, other signalling pathways and the ability of AZD8931 to inhibit the growth of EGFR responsive anti-hormone-resistant breast cancer lines

Funder
AstraZeneca UK Ltd

Principal Investigator

None Yet Associated


Co-Investigators
Gee, Julia


Project Details

Net value award figure for Cardiff University: £205,525.00

Start date: 01/09/2009

End date: 31/03/2012


Last updated on 2024-24-03 at 04:32